Literature DB >> 16203279

Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.

Yin Xu1, Robert W McKenna, Nitin J Karandikar, Alex J Pildain, Steven H Kroft.   

Abstract

To determine whether immunophenotypic features of monocytes are useful in differentiating chronic myelomonocytic leukemia (CMML) from reactive monocytosis, multiparameter flow cytometry was used to immunophenotype 20 bone marrow samples from patients with CMML, 10 normal marrow samples, and 20 marrow samples with reactive monocytosis. Monocytes in CMML exhibited aberrant antigen expression in all 20 cases. Abnormal antigen expression also was observed in monocytes in 11 of 20 reactive marrow samples. However, aberrant expression of 2 or more antigens was significantly less frequent in reactive monocytosis than in CMML (P = .002). CD56 expression with underexpression of a myeloid marker was unique to CMML monocytes. Subpopulations of monocytes with moderate levels of CD14 were present in all 3 groups. The proportion of CD14(moderate) monocytes was highest in CMML and was 20% or more in 13 of 20 CMML cases vs 3 of 20 reactive marrow samples (P = .003) and 2 of 10 normal marrow samples (P = .007). A combination of monocytosis with 2 or more immunophenotypic aberrancies with 20% or more of marrow monocytes showing moderate CD14 expression was 67% sensitive and 100% specific for CMML.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203279     DOI: 10.1309/HRJ1-XKTD-77J1-UTFM

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.

Authors:  Juraj Bies; Marek Sramko; Joanna Fares; Michael Rosu-Myles; Steven Zhang; Richard Koller; Linda Wolff
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

Review 2.  Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and Beyond.

Authors:  Siba El Hussein; Joseph D Khoury; L Jeffrey Medeiros; Sanam Loghavi
Journal:  Curr Hematol Malig Rep       Date:  2021-05-04       Impact factor: 3.952

3.  Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.

Authors:  Dorothée Selimoglu-Buet; Orianne Wagner-Ballon; Véronique Saada; Valérie Bardet; Raphaël Itzykson; Laura Bencheikh; Margot Morabito; Elisabeth Met; Camille Debord; Emmanuel Benayoun; Anne-Marie Nloga; Pierre Fenaux; Thorsten Braun; Christophe Willekens; Bruno Quesnel; Lionel Adès; Michaela Fontenay; Philippe Rameau; Nathalie Droin; Serge Koscielny; Eric Solary
Journal:  Blood       Date:  2015-04-07       Impact factor: 22.113

4.  Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib.

Authors:  Jia Gu; Zhiqiong Wang; Min Xiao; Xia Mao; Li Zhu; Ying Wang; Wei Huang
Journal:  Cancer Biol Ther       Date:  2017-01-19       Impact factor: 4.742

5.  The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia.

Authors:  Marwan Qubaja; Béatrice Marmey; Agnès Le Tourneau; Stéphanie Haiat; Dominique Cazals-Hatem; Bettina Fabiani; Jacques Diebold; Jean-Pierre Marie; Josée Audouin; Frédéric Geissmann; Thierry Jo Molina
Journal:  Virchows Arch       Date:  2009-02-26       Impact factor: 4.064

6.  Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

Authors:  Arjan A van de Loosdrecht; Canan Alhan; Marie Christine Béné; Matteo G Della Porta; Angelika M Dräger; Jean Feuillard; Patricia Font; Ulrich Germing; Detlef Haase; Christa H Homburg; Robin Ireland; Joop H Jansen; Wolfgang Kern; Luca Malcovati; Jeroen G Te Marvelde; Ghulam J Mufti; Kiyoyuki Ogata; Alberto Orfao; Gert J Ossenkoppele; Anna Porwit; Frank W Preijers; Stephen J Richards; Gerrit Jan Schuurhuis; Dolores Subirá; Peter Valent; Vincent H J van der Velden; Paresh Vyas; August H Westra; Theo M de Witte; Denise A Wells; Michael R Loken; Theresia M Westers
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

Review 7.  Clinical and Molecular Approach to Adult-Onset, Neoplastic Monocytosis.

Authors:  Rory M Shallis; Alexa J Siddon; Amer M Zeidan
Journal:  Curr Hematol Malig Rep       Date:  2021-04-22       Impact factor: 3.952

8.  Leishmania specific CD4 T cells release IFNγ that limits parasite replication in patients with visceral leishmaniasis.

Authors:  Rajiv Kumar; Neetu Singh; Shalini Gautam; Om Prakash Singh; Kamlesh Gidwani; Madhukar Rai; David Sacks; Shyam Sundar; Susanne Nylén
Journal:  PLoS Negl Trop Dis       Date:  2014-10-02

9.  Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells.

Authors:  Valérie Faivre; Anne-Claire Lukaszewicz; Didier Payen
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

10.  CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence.

Authors:  Marco Krasselt; Christoph Baerwald; Ulf Wagner; Manuela Rossol
Journal:  Arthritis Res Ther       Date:  2013-10-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.